TTrialPathMatch Me to Trials
← Back to trials
RecruitingEsophagectomyPostoperative ComplicationsInfections

Infectious Complications After Esophagectomy

Eligible age

18+ yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Infectious complications represent the most common postoperative adverse events following esophagectomy for cancer, such as pneumonia (15% of cases). These complications increase immediate risks, lengthen hospital stays, and worsen patient quality of life. The population includes patients admitted to intensive care after esophagectomy for cancer between January 1, 2017, and December 31, 2024. The study focuses on this population due to the increasing incidence of esophageal cancer, the increased use of surgery for these indications, and the importance of postoperative infections in these complex procedures, despite their understudied nature in the current literature. Identifying modifiable risk factors could lead to corrective measures and thus improve the prognosis of postoperative patients. The research focuses primarily on the incidence, types, factors, and prognosis associated with the occurrence of infections after esophagectomy for cancer. It also includes an analysis of the pathogens involved, their resistance profiles, and the antibiotic therapies used in first-line probabilistic treatment.

Sponsor: Assistance Publique - Hôpitaux de Paris

You may qualify if…

  • Patients over 18 years of age
  • Underwent esophagectomy for cancer between January 1, 2017, and December 31, 2024
  • Scheduled admission to intensive care for postoperative monitoring

You may not qualify if…

  • Opposition to the use of data

Source: ClinicalTrials.gov · NCT06911658 · last updated 2025-12-17

Infectious Complications After Esophagectomy · TrialPath